
Cardiovascular Systems CSII
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Cardiovascular Systems Betriebsaufwand 2011-2026 | CSII
Betriebsaufwand Jährlich Cardiovascular Systems
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 209 M | 210 M | 215 M | 201 M | 175 M | 167 M | 188 M | 175 M | 139 M | 102 M | 77.7 M | 71.3 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 215 M | 71.3 M | 161 M |
Betriebsaufwand Vierteljährlich Cardiovascular Systems
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51.5 M | 53.9 M | 105 M | 51.1 M | 49.6 M | 52.2 M | 102 M | 54.9 M | 50 M | 49.6 M | 50 M | 51.7 M | 58 M | 57.8 M | 58 M | 57.8 M | 48.3 M | 48.7 M | 48.3 M | 48.7 M | 43.4 M | 42.2 M | 43.4 M | 42.2 M | 39.8 M | 42.2 M | 39.8 M | 42.2 M | 48.5 M | 48.3 M | 48.5 M | 48.3 M | 40.6 M | 40.7 M | 40.6 M | 40.7 M | 32.5 M | 29.7 M | 32.5 M | 29.7 M | 24.5 M | 23.2 M | 24.5 M | 23.2 M | 18.8 M | 17.4 M | 18.8 M | 17.4 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 105 M | 17.4 M | 44.4 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Alphatec Holdings
ATEC
|
614 M | $ 11.07 | 1.56 % | $ 1.66 B | ||
|
Cytosorbents Corporation
CTSO
|
41.2 M | $ 0.57 | -6.52 % | $ 35.5 M | ||
|
AxoGen
AXGN
|
121 M | $ 32.3 | 1.06 % | $ 1.49 B | ||
|
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | ||
|
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M | ||
|
Align Technology
ALGN
|
2.19 B | $ 175.18 | 1.18 % | $ 13.1 B | ||
|
AdaptHealth Corp.
AHCO
|
59.6 M | $ 12.3 | 1.07 % | $ 1.66 B | ||
|
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | ||
|
Helius Medical Technologies
HSDT
|
12.5 M | $ 1.86 | -1.59 % | $ 1.13 M | ||
|
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | ||
|
Inogen
INGN
|
184 M | $ 6.49 | 2.53 % | $ 173 M | ||
|
IRIDEX Corporation
IRIX
|
21.8 M | $ 0.98 | -1.7 % | $ 16.6 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | ||
|
Bio-Rad Laboratories
BIO
|
1.03 B | $ 283.23 | 1.42 % | $ 7.99 B | ||
|
BioSig Technologies
BSGM
|
71.1 M | - | 37.08 % | $ 85.7 M | ||
|
EDAP TMS S.A.
EDAP
|
20.8 M | $ 3.32 | 0.61 % | $ 124 M | ||
|
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
1.4 B | $ 38.06 | 1.25 % | $ 5.67 K | ||
|
Boston Scientific Corporation
BSX
|
10.2 B | $ 62.49 | 1.13 % | $ 92.5 B | ||
|
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | ||
|
LivaNova PLC
LIVN
|
697 M | $ 63.28 | 0.8 % | $ 3.45 B | ||
|
LENSAR
LNSR
|
32.6 M | $ 5.85 | 2.63 % | $ 70 M | ||
|
ClearPoint Neuro
CLPT
|
15.3 M | $ 9.18 | 5.76 % | $ 260 M | ||
|
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | ||
|
Electromed
ELMD
|
40.3 M | $ 24.08 | -0.17 % | $ 204 M | ||
|
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | ||
|
Second Sight Medical Products
EYES
|
27.6 M | - | -0.97 % | $ 54.4 M | ||
|
Aziyo Biologics
AZYO
|
33.5 M | - | 1.37 % | $ 20.5 M | ||
|
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | ||
|
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | ||
|
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | ||
|
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M | ||
|
Sintx Technologies
SINT
|
11.2 M | $ 2.9 | 8.21 % | $ 8.04 M | ||
|
OrthoPediatrics Corp.
KIDS
|
212 M | $ 16.41 | 2.76 % | $ 385 M | ||
|
Globus Medical
GMED
|
547 M | $ 91.47 | 1.16 % | $ 12.4 B | ||
|
Butterfly Network
BFLY
|
123 M | $ 4.14 | 0.61 % | $ 876 M | ||
|
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | ||
|
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | ||
|
Stryker Corporation
SYK
|
11.2 B | $ 341.83 | 0.79 % | $ 131 B | ||
|
Delcath Systems
DCTH
|
72.8 M | $ 10.25 | 2.09 % | $ 367 M | ||
|
TELA Bio
TELA
|
88.1 M | $ 0.55 | -3.05 % | $ 25.8 M | ||
|
Myomo
MYO
|
41.3 M | $ 0.7 | 1.46 % | $ 29.3 M | ||
|
Inspire Medical Systems
INSP
|
240 M | $ 54.27 | 0.46 % | $ 1.59 B | ||
|
CONMED Corporation
CNMD
|
648 M | $ 36.75 | 0.03 % | $ 1.14 B |